Connexin 43 hemichannels mediate spatial and temporal disease spread in ALS
Almad, A. A.; Taga, A.; Joseph, J.; Welsh, C.; Patankar, A.; Gross, S. K.; Richard, J.-P.; Pokharel, A.; Lillo, M.; Dastgheyb, R.; Eggan, K.; Haughey, N.; Contreras, J. E.; Maragakis, N. J.
Show abstract
Connexin 43 (Cx43) gap junctions and hemichannels mediate astrocyte intercellular communication in the central nervous system under normal conditions and may contribute to astrocyte-mediated neurotoxicity in amyotrophic lateral sclerosis (ALS). Here we show that astrocyte-specific knockout of Cx43 in a mouse model of ALS slows disease progression both spatially and temporally, provides motor neuron (MN) protection, and improves survival. In human ALS tissues and biofluids, we observe that higher levels of Cx43 correlate with accelerated disease progression. Using human iPSC-derived astrocytes (hiPSC-A) from both familial and sporadic ALS, we show that Cx43 is upregulated and that Cx43-hemichannels are enriched at the astrocyte membrane. We then demonstrate that the pharmacological blockade of Cx43-hemichannels in ALS astrocytes, during a specific temporal window, provides neuroprotection of hiPSC-MN and reduces ALS astrocyte-mediated neuronal hyperexcitability. Our data identify Cx43 hemichannels as novel conduits of astrocyte-mediated disease progression and a pharmacological target for disease-modifying ALS therapies.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides 95%
- Novel extracellular vesicle release pathway facilitated by toxic superoxide dismutase 1 oligomers 95%
- Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons 94%
Similar papers in this journal
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease 94%
- Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model 94%
- Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Expression of ALS-PFN1 impairs vesicular degradation in iPSC-derived microglia 96%
- Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases 96%
- Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.